Extravasation/Infiltration Management Chart
Docetaxel X € Moderate to severe pain DOPamine* X € Skin tight, leaking DOXorubicin X X € Skin discolored, bruised, swollen Doxycycline* X X € Deep pitting tissue edema Epinephrine* X € Gross edema >6" in any direction Erythromycin X € Circulatory impairment Esmolol X X € Blood product, irritant, or vesicant infiltration Etomidate ...
Download Extravasation/Infiltration Management Chart
Information
Domain:
Source:
Link to this page:
Documents from same domain
Pediatric Pharmacy Inpatient Care Programs
pedsrx.johnshopkins.eduThe Pediatric Pharmacy Inpatient Programs are managed by our Pediatric Clinical Pharmacy Specialists ... & Cardiology/Heart Transplant Cell: (609) 937 – 6202 1. Call Cell 2. CORUS ... inpatient anticoagulation requires pharmacists to complete a warfarin competency, followed by evaluation. ...
Parenteral Nutrition Recommendations for Pediatric Patients
pedsrx.johnshopkins.eduJul 13, 2018 · July 13, 2018 . PN Additives Indications for Use Dosing Trace Elements All patients, unless direct hyperbilirubinemia or otherwise indicated. Auto defaults in EPIC to weight based dosing. You will need to modify dosing if hyperbilirubinemia (Dbili >2).
Related documents
BC Cancer Extravasation Hazard Table
www.bccancer.bc.caBC Cancer Extravasation Hazard Table (Systemic Therapy Policy III-20) Developed: 1 November 2014 Revised: 1 December 2021 BC Cancer Extravasation Hazard Table
James Patient Education Handouts A-Z
healthsystem.osumc.eduDocetaxel Doxorubicin Liposomal (Doxil) James Patient Education Handouts (A – Z) Click on the title to see the handout To narrow your search use “Ctrl + F” and enter a keyword . The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
POTENTIAL IRRITANT MEDICATIONS
mi-hms.orgPOTENTIAL IRRITANT MEDICATIONS * (Consider administration via central venous catheter – should not administer via Midline) *An irritant is an agent capable of producing discomfort or pain along the internal lumen of the vein (s 105 INS SOP …
PRINCIPLES OF CHEMOTHERAPY IN CANCER
oncologypro.esmo.orgDoxorubicin Doxorubicin Liposomal Epirubicin Idarubicin Mitomycin Mitoxantrone. MITOTIC SPINDLE AGENTS Docetaxel Paclitaxel Paclitaxel Albumin Cabazitaxel Vincristine Vinblastine Vinorelbine Mechanism of action: Bind to microtubular proteins, thus inhibit microtubule assembly resulting in dissolution of the
Reference ID: 3101735
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. 1.2 Non-Small Cell Lung Cancer . Docetaxel Injection as a single agent is indicated …
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eupatients receiving Herceptin therapy alone or in combination with paclitaxel or docetaxel, particularly following anthracycline (doxorubicin or epirubicin) containing chemotherapy. These may be moderate to severe and have been associated with death (see section 4.8). In addition, caution should be